The ability of carbon-based nanomaterials (CNM) to interact with a variety of pharmaceutical
drugs can be exploited in many applications. In particular, they have been studied both as …

The uncontrolled release of pharmaceutical drugs into the environment raised serious
concerns in the last decades as they can potentially exert adverse effects on living …

The monofunctional platinum drug phenanthriplatin (phenPt) blocks the replication of cancer
cells even if it reacts with only one guanine base. However, there is still insufficient …

The complex formation between a cyclic ligand glutarimidoxioxime (denoted as HLIII in this
paper) and UO22+ is studied by potentiometry and microcalorimetry. Glutarimidoxioxime …

The Pt-catalysed addition of silanes to functional groups such as alkenes, alkynes,
carbonyls and alcohols, ie the hydrosilylation reaction, is a fundamental transformation in …

The platination processes of DNA bases with second-and third-generation Pt (II) anticancer
drugs have been investigated using density functional theory (DFT) combined with the …

Phenanthriplatin (PtPPH) is a monovalent platinum (II)-based complex with a large
cytotoxicity against cancer cells. Although the aqua-activated drug has been assumed to be …

The complexes of Cu (I) and Ag (I) with 1, 3, 5-triaza-7-phosphadamantane (PTA) are
currently studied for their potential clinical use as anticancer agents, given the cytotoxicity …

Picoplatin, cis-[PtCl2 (NH3)(2-picoline)], is a new promising anticancer agent undergoing
clinical trials, which reveals high efficacy against many tumors and greatly reduced toxicity …

The hydration of the cisplatin aqua-derivatives, cis-[PtCl (H2O)(NH3) 2]+(w-cisplatin) and cis-
[Pt (H2O) 2 (NH3) 2] 2+(w2-cisplatin), has been studied by means of classical molecular …